Change Ad Consent
Do not sell my data
Reply to thread | The Boneyard
Menu
Forums
New posts
Search forums
What's new
New posts
Latest activity
Chat
UConn Football Chat
UConn Men's Basketball
UConn Women's Basketball
Media
The Uconn Blog
Verbal Commits
This is UConn Country
Field of 68
CT Scoreboard Podcasts
A Dime Back
Sliders and Curveballs Podcast
Storrs Central
Men's Basketball
News
Roster
Schedule
Standings
Women's Basketball
News
Roster
Schedule
Standings
Football
News
Roster
Depth Chart
Schedule
Football Recruiting
Offers
Commits
Donate
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Install the app
Install
Forums
UConn Athletics
UConn Men's Basketball Forum
COVID-19 Presentation from CROI Meeting
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
[QUOTE="pj, post: 3480897, member: 2524"] JBM, I have no idea why you think I don't understand infectivity and the molecular biology of binding. I am a PhD scientist with decades of experience in molecular biology and therapeutics. The reason I pointed to gene sequence similarity is because it addresses the question of virus origins. I was not discussing virulence at all. As for the data in bats, there is no evidence at all of strain evolution in bats toward or anywhere near SARS-CoV-2. There is no evidence of a bat pool of coronavirus diversity that encompasses any of the key genetic components of SARS-CoV-2, much less the whole virus. Obviously, I was persuaded by the Tang et al report that there are two strains, a lethal strain that first appeared in November in Wuhan and is responsible for the high early death rate and the high death rate in places like Iran that received the lethal strain, and a weakened strain that first appeared in China in December or January. I think [U]that aspect of the paper[/U] is highly likely to be correct, as it is hard to imagine another explanation for the extreme variations we've seen in lethality by outbreak, some outbreaks at 5-20% lethality and some at 0.1-1% lethality. The critique of Tang et al you point to makes some reasonable objections to issues with the Tang paper (which I think cannot be totally honest due to constraints from the Chinese government), but they don't refute the idea that there are L and S strains. I think Tang et al know more than they have said and have highlighted for us two key mutations which, as time will show, greatly weaken virulence and turn the virus into a de facto "vaccine" against the lethal version. All of these questions will be resolved as we get more sequences from patients in the West and correlate them with outcomes, and observe whether and in what circumstances re-infections occur. As for your idea that most deaths were early and now there is some health care response that is mitigating death -- no, not in Italy. The healthcare response is not substantially better now in Europe than it was in Wuhan in January. If more people died in Wuhan, it is because the strain they contracted was more lethal. That lethal strain still has the potential to grow and spread. We are not yet safe from it. [/QUOTE]
Verification
First name of men's bb coach
Post reply
Forums
UConn Athletics
UConn Men's Basketball Forum
COVID-19 Presentation from CROI Meeting
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top
Bottom